Cite

HARVARD Citation

    Moiola, L. et al. (2021). The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement. Multiple sclerosis. pp. 331-346. [Online]. 
  
Back to record